IDEXX Laboratories (IDXX) reported Q1 earnings Thursday of $2.96 per diluted share, up from $2.81 a year earlier.

Analysts polled by FactSet expected $2.85.

Revenue for the quarter ended March 31 was $998.4 million, up from $964.1 million a year earlier.

Analysts surveyed by FactSet expected $997.1 million.

For 2025, the company lifted its earnings guidance to $11.93 to $12.43 on revenue of $4.10 billion to $4.21 billion from a previous estimate of $11.74 to $12.24 on revenue of $4.06 billion to $4.17 billion.

Analysts polled by FactSet expect EPS of $11.98 on revenue of $4.11 billion.

Shares of the company were up more than 1.5% in recent premarket activity.